SPRD Cy is a spontaneous rat model of polycystic kidney disease (PKD) caused by a missense mutation in Pkdr1. Cystogenesis in this model is not clearly understood. In the current study, we performed global gene expression profiling in early-stage PKD cyst development in Cy/Cy kidneys and normal (ϩ/ϩ) kidneys at 3 and 7 days of postnatal age. Expression profiles were determined by microarray analysis, followed by validation with real-time RT-PCR. Genes were selected with over 1.5-fold expression changes compared with agematched ϩ/ϩ kidneys for canonical pathway analysis. We found nine pathways in common between 3-and 7-day Cy/Cy kidneys. Three significantly changed pathways were designated "Vitamin D Receptor (VDR)/Retinoid X Receptor (RXR) Activation," "LPS/IL-1-Mediated Inhibition of RXR Function," and "Liver X Receptor (LXR)/RXR Activation." These results suggest that RXR-mediated signaling is significantly altered in developing kidneys with mutated Pkdr1. In gene ontology analysis, the functions of these RXR-related genes were found to be involved in regulating cell proliferation and organ morphogenesis. With real-time RT-PCR analysis, the upregulation of Ptx2, Alox15b, OSP, and PCNA, major markers of cell proliferation associated with the RXR pathway, were confirmed in 3-and 7-day Cy/Cy kidneys compared with 3-day ϩ/ϩ kidneys. The increased RXR protein was observed in both the nucleus and cytoplasm of cystic epithelial cells in early-stage Cy/Cy kidneys, and the RXRpositive cells were strongly positive for PCNA staining. Taken together, cell proliferation and organ morphogenesis signals transduced by RXR-mediated pathways may have important roles for cystogenesis in early-stage PKD in this Pkdr1-mutated Cy rat.
ADPKD; retinoid X receptor; proliferation AUTOSOMAL DOMINANT POLYCYSTIC kidney disease (ADPKD), caused by mutations in the PKD1 or PKD2 genes, is one of the most common hereditary disorders in humans. It is characterized by having abnormal morphological growth of renal tubules that leads to the formation of fluid-filled cysts, extracellular matrix remodeling, and interstitial inflammation and fibrosis (14, 32) . Polycystin-1 (PC-1) and polycystin-2 (PC-2), the products of the PKD1 and PKD2 genes, are thought to form a Ca 2ϩ -permeable cation channel (13, 47, 57) , and they colocalize to primary cilia of cells (26, 27, 56) as well as to other cellular sites. Recent evidence has shown that intracellular Ca 2ϩ levels are lower in epithelial cells isolated from human ADPKD cysts, compared with normal tubular epithelial cells, and that cAMP agonists can abnormally stimulate the proliferation of these cells by activating the B-Raf/MEK/ERK pathway (53, 54) . Other pathways, including AKT/mammalian target of rapamycin (mTOR) and Wnt/␤-catenin, have also been implicated in cystogenesis (9, 17, 33) . Therefore, several interacting pathways may have roles in cystogenesis and in the progression of PKD.
The Han:SPRD Cy strain, a spontaneous rat model of dominantly inherited PKD, has a missense mutation (R823W) in the Anks6 (Pkdr1) gene (1) . The gene product, SamCystin, contains ankyrin repeats (ANK) and a sterile ␣-motif (SAM), which are thought to be involved in protein-protein interactions (1) . This mutation may disrupt interactions between SamCystin and cell signaling proteins. However, the role of the Pkdr1 gene mutation in cyst formation is not fully understood. Homozygous Cy/Cy rats have rapid disease progression and die of renal failure by approximately 3 wk of age (7) . In contrast, the renal tubules of Cy/ϩ rats appear to develop normally until ϳ2-3 wk of age. In both Cy/Cy and Cy/ϩ, renal cysts form from proximal tubules as a consequence of increased epithelial cell proliferation, and cyst formation is associated with morphological dedifferentiation, tubule basement membrane thickening, and infiltration and aggregation of monocytes (6, 7, 34, 39) . The B-Raf/MEK/ERK and AKT/mTOR pathways are upregulated in the kidneys of young adult-stage Cy/ϩ rats (24, 25, 49) , suggesting that this is a useful human disease model for understanding cystogenesis and for evaluating the efficacy of candidate drugs for ADPKD patients (11, 12, 21, 23, 48) .
Global gene expression profiling has provided comprehensive evaluations of PKD-related transcriptional activity in 10-day-old cpk/cpk recessive mouse and homozygous Cy/Cy rat models, which both die with renal failure at ϳ3 wk of age. In these cases, significant PKD-specific transcriptional abnormalities were found that reflect the more advanced stages of cyst formation at or just before renal failure (4, 22, 35) . In the present study, we have specifically examined the earliest stages of cyst formation in 3-and 7-day-old Han:SPRD Cy homozygous and heterozygous rats to identify signaling pathways in the initial stages of cyst formation that are first affected by the earliest abnormal cellular events leading to cyst formation, and to better understand the early developmental events in the cyst-forming process that may provide novel therapeutic strategies for ADPKD.
METHODS

Animals.
Han:SPRD Cy rats were maintained at the Education and Research Center of Animal Models for Human Diseases at Fujita Health University (23) (24) (25) 49) . Rats were anesthetized at 3 and 7 days of age with pentobarbital sodium (Schering-Plough, Kenilworth, NJ), and both kidneys were removed rapidly, causing exsanguination. One normal (ϩ/ϩ), Cy/ϩ, and Cy/Cy male at 3 days and two ϩ/ϩ, Cy/ϩ, and Cy/Cy males at 7 days were used for microarray assay; also, five ϩ/ϩ, Cy/ϩ, and Cy/Cy males at both 3 and 7 days were used for real-time RT-PCR. The right kidney was immersed in 4% paraformaldehyde, embedded in paraffin, and sectioned for hematoxylin and eosin staining and immunohistochemistry. The left kidney was frozen in liquid nitrogen for RNA extraction. For protein expression, the kidney was homogenized in lysis buffer to extract proteins. Blood samples were collected for serum urea nitrogen (SUN) as an indication of kidney function. SUN measurement was performed with a colorimetric assay using a urease-indophenol method (Wako Pure Chemical Industries, Osaka, Japan). The protocols for the use of these animals were approved by the Animal Care and Use Committee of Fujita Health University.
Genotyping. Mutational analysis revealed that a C-to-T transition in the Pkdr1 gene was responsible for PKD in Han:SPRD rats (1). Normal, Cy/ϩ, and Cy/Cy rats were genotyped using a PCR-RFLP method as described previously by Brown et al. (1) . PCR products were obtained using the Applied Biosystems GeneAmp PCR System 9700.
RNA extraction. RNA was extracted from kidneys of 3-and 7-day-old rats using a monophasic solution of phenol/guanidine isothiocyanate and TRIzol reagent (Invitrogen, Carlsbad, CA) in accordance with their manual, and the samples were incubated with RNase-free DNase I (Ambion). The quality and concentration of each sample were confirmed by spectrophotometry (NanoDrop ND-1000; Asahi Glass, Tokyo, Japan).
Microarrays. DNA microarray experiments were performed essentially as described previously (7). Briefly, 200-ng aliquots of total RNA obtained from kidneys of 3-or 7-day-old rats were labeled using an Agilent Low RNA Input Fluorescent Linear Amplification Kit (Agilent Technologies, Santa Clara, CA) according to the manufacturer's instructions. The pooled renal RNAs of ϩ/ϩ, Cy/ϩ, or Cy/Cy rats were labeled with Cy5 fluorescent dye, and the pooled renal RNAs of ϩ/ϩ rats adopted as the template control were labeled with Cy3 fluorescent dye. After determination of labeling efficiency, 1-g aliquots of Cy3-labeled RNA obtained from age-matched ϩ/ϩ kidneys and Cy5-labeled RNA from ϩ/ϩ, Cy/ϩ, or Cy/Cy kidneys were mixed and hybridized onto Agilent Rat Oligo Microarrays (product no. G4130A) according to the manufacturer's hybridization protocol. The microarray slides were examined with an Agilent microarray scanner and software (scanner model G2565BA). Data analysis was performed with Agilent Feature Extraction software (version A.7.1.1) and Excel 2003 (Microsoft). Data from microarray experiments from 3-and 7-day-old rats were analyzed independently. Primary microarray data are available from the Gene Expression Omnibus (GEO; accession no. GSE23079). These data were imported into GeneSpring GX 7.3 (Agilent Technologies), with per-spot, per-chip, and intensitydependent (Lowess) normalization being applied to each array. To avoid false-positive signals, genes were excluded for which base/ proportional levels were decided by the cross-gene error model of GeneSpring GX 7.3, as reported previously (41) . The ratio of the normalized signals (Cy5/Cy3) was used to assess the relative levels of expression among the samples. Using the GeneSpring software, gene ontology (GO) analysis was performed, in which genes were organized into hierarchical categories based on biological process. Canon- Real-time RT-PCR. cDNA was produced from total RNA by reverse transcriptase using random hexamer primers (SuperScript II First Strand Synthesis System; Invitrogen). To compare gene expression patterns of Cy/Cy with the normal genotype, we selected the following genes: paired-like homeodomain transcription factor 2 (Ptx2), arachidonate 15-lipoxygenase second type (Alox15b), secreted phosphoprotein 1 (OSP), and proliferating cell nuclear antigen (PCNA). Gene expression was detected by real-time RT-PCR (ABI 7300 real-time PCR system; Applied Biosystems, Foster City, CA) using the TaqMan reagent-based chemistry protocol. GAPDH as a housekeeping gene was used for data normalization. The probes are shown in Supplemental Table S1 (all supplemental material for this article is available on the journal web site). Relative quantification of gene expression was compared with 3-day-old ϩ/ϩ kidneys (set to 1.0).
Western blot analysis. Kidney lysates were prepared for immunoblotting as described previously (19, 20) . Proteins (20 g protein/ lane) were separated by 10% SDS-PAGE and transferred to nitrocellulose membranes. Membranes were incubated overnight at 4°C in primary retinoid X receptor (RXR)-␣ (D-20, SC-553, 1:1,000; Santa Cruz Biotechnology, Santa Cruz, CA) or GAPDH antibody (1:10,000, ab8245; Abcam, Cambridge, UK) and incubated with secondary antibody conjugated to horseradish peroxidase diluted 1:10,000 in 2% milk in TBS-T. Specific antibody signals were detected using an enhanced chemiluminescence system (ECL Advance Western Blotting Detection System; Amersham Life Sciences, Arlington Heights, IL). Images of the blots were captured, and the intensity of the protein bands was quantified using a CS Analyzer 2.0 with a CCD camera (ATTO, Tokyo, Japan). Relative band intensity was compared with ϩ/ϩ kidneys of 3-day-old rats (set to 1.0).
Immunohistochemistry. Kidney sections were prepared for immunoreaction as described previously (24, 25) . Sections were incubated with RXR (1:50) or PCNA (1:10,000 p8825; Sigma, St. Louis MO) in PBS containing 1% BSA plus 0.05% NaN 3 overnight at 4°C. To test for a specific RXR immunoreaction in the kidney, a blocking peptide (SC-553P; Santa Cruz Biotechnology) was used with the RXR antibody. Sections were incubated with secondary antibody HISTOFINE MAX-PO (MULTI: for anti-mouse/rabbit IgGϩIgAϩIgM) obtained from Nichirei Biosciences. Immune reaction products were developed using 3,3=-diaminobenzidine (ENVISION kit, HRP Dako Cytomation K3466; Dako Japan, Tokyo, Japan).
Statistical analysis. Results are expressed as means Ϯ SE. Statistical comparisons between groups were performed by Student's t-test and two-way analysis of variance, and differences were considered to be significant at P Ͻ 0.05.
RESULTS
Degree of disease progression in early-stage PKD.
To confirm the degree of PKD progression in 3-and 7-day-old Han:SPRD rats, we examined hematoxylin-and eosin-stained kidneys, measured kidney weight per body weight (%KB), and determined SUN levels (Supplemental Fig. S1 ). Dilated renal proximal tubules were observed in limited areas in both 3-and 7-day Cy/ϩ kidneys. The number and sizes of the dilated tubules were increased at 7 days. Cysts were easily seen in both 3-and 7-day Cy/Cy kidneys, and the sizes of cysts were significantly increased at 7 days (7). %KB, an indication of overall cystic kidney size, was increased in Cy/ϩ rats at 3 and 7 days, and in Cy/Cy rats at 3 and 7 days, compared with those of age-matched ϩ/ϩ animals. SUN levels, a renal function marker, increased significantly at 3 and 7 days of age in Cy/Cy rats. The Cy/ϩ kidneys showed early cyst formation at 3 and 7 days, with no evidence of increased SUN, whereas Cy/Cy kidneys showed increased cyst enlargement at 3 and 7 days, with progressively increased SUN. The findings indicate that the kidneys at 3 and 7 days of age are appropriate for evaluating gene expression profiles in early-stage PKD.
Identification of differentially expressed genes by expression profiling. An overview of the microarray expression profiling analysis is shown in Supplemental Fig. S2 . Among the 41,127 genes spotted on the microarray slide, 22,547 and 24,403 genes, respectively, had reliable signal intensities for 3-and 7-day-old rats. Supplemental Fig. S2 compares the Cy genotypes using an overlapping line plot. Cy/Cy kidneys showed a greater variation in expression level (dynamic range) relative to ϩ/ϩ kidneys than did Cy/ϩ kidneys relative to ϩ/ϩ Pathways in common between 7-day Cy/ϩ, 3-day Cy/Cy, and 7-day Cy/Cy rat kidneys with P values Ͻ0.05 (Ͻ5.00E-02). LXR, liver X receptor; RXR, retinoid X receptor; VDR, vitamin D receptor. P values were obtained from the Ingenuity Pathway Analysis software compared with age-matched ϩ/ϩ controls. Underlined values are Ͻ0.01 (Ͻ1.00E-02). Common pathways are indicated arbitrarily in order of P value for the 3-day Cy/Cy column (top left) or for the 7-day Cy/ϩ columns (middle and bottom left). Signaling pathway analysis. To identify the abnormally altered signaling pathways in early-stage cystic kidneys, we selected the 1,415 genes at 3 days and the 3,168 genes at 7 days, as having changed over 1.5-fold in Cy/Cy, for canonical pathway analysis using Ingenuity Pathway Analysis (IPA). It was possible to assign 25 pathways to the 1,415 genes at 3 days (P Ͻ 0.05) and 32 pathways to the 3,168 genes at 7 days (P Ͻ 0.05). We obtained nine common pathways from all these pathways at 3 and 7 days ( Table 2 ). The pathway with the most overall change at 3 and 7 days in Cy/Cy kidneys compared with age-matched ϩ/ϩ kidneys was "Liver X Receptor (LXR)/ RXR Activation." Furthermore, the P value of "Hepatic Fibrosis/Hepatic Stellate Cell Activation" (7.41E-04), "LPS/IL-1-Mediated Inhibition of RXR Function" (2.14E-03), and "Vitamin D Receptor (VDR)/RXR Activation" (5.62E-05) were Ͻ1.00E-02 at 7 days (Table 2) . Intriguingly, the names of these three pathways contained RXR. Therefore, we searched for the keyword RXR in the individual gene names for both ages of Cy/Cy and found "Transcriptional Regulator (TR)/RXR Activation" (P ϭ 3.89E-02) at 3 days of age. "Peroxisome Proliferator-Activated Receptor (PPAR)-␣/RXR-␣" (P ϭ 4.07E-04), "Farnesoid X Receptor (FXR)/RXR" (P ϭ 1.07E-03), and "Pregnane X Receptor (PXR)/RXR" (P ϭ 1.12E-02) were detected in the gene names at 7 days of age.
To determine whether RXR-mediated pathways are also involved in slower progressing PKD, we selected 525 genes as having changed over 1.5-fold in 7-day-old Cy/ϩ kidneys compared with age-matched ϩ/ϩ kidneys and looked for canonical pathways. Interestingly, RXR-mediated pathways were four of the top seven most significant canonical pathways: LPS/IL-1-Mediated Inhibition of RXR Function (P ϭ 4.17E-05), PXR/RXR Activation (P ϭ 5.50E-04), VDR/RXR Activation (P ϭ 8.71E-03), and FXR/RXR Activation (P ϭ 1.07E-02) (Table 2) , although expression of RXR itself in 3-and 7-day Cy/ϩ kidneys did not differ from age-matched ϩ/ϩ kidneys (data not shown). These findings suggested that RXRmediated pathways may have an important role in cystogenesis in this Pkdr1-mutated strain with both Cy/ϩ and Cy/Cy phenotypes. Table 3 RXR is a ligand-dependent nuclear receptor (NR) that forms a complex with other ligand-dependent NRs and transcriptional receptors (TRs) and functions to regulate signal transduction, cell proliferation, morphology, and apoptosis (5, 28, 30, 31, 36, 46) . To examine this further, we looked for all the differentially expressed RXR/(NR/TR)-regulated genes in Cy/Cy kidneys and found 83 genes regulated by RXR/(NR/TR) in 3-day and 204 genes in 7-day Cy/Cy rats. Table 3 shows all upregulated and downregulated genes related to RXR/(NR/TR) regulation that are in common at 3 and 7 days.
In Cy/Cy kidneys, GO analysis denoted 261 functional categories from the 83 genes regulated by RXR/(NR/TR) at 3 days and 413 functional categories from the 204 genes regulated by RXR/(NR/TR) at 7 days (P Ͻ 0.05). We obtained 15 common GO categories from 30 functional categories at 3 days (P Ͻ 1.00E-03) and 33 functional categories at 7 days (P Ͻ 1.00E-05) ( Table 4 ). Four functional categories, i.e., cell proliferation (GO:8283), organ development (GO:48513), morphogenesis (GO:9653), and regulation of cell proliferation, (GO:42127) are listed in Table 4 as biological processes regulated by RXR/(NR/TR). Cellular proliferation and organ development and morphogenesis are important in PKD (6, 7, 14, 21, 23-25, 32, 34, 39, 48, 49) . In contrast, the functional categories relating to PKD progression including extracellular matrix organization and biogenesis (GO:30198), collagen fibril organization (GO:30199), positive regulation of ion transport (GO:43270), anion transport (GO:6820), and regulation of secretion (GO:51046) were not identified (Table 4 ). These findings suggest that genes associated with the RXR pathway are involved in cell proliferation, differentiation, and morphogenesis rather than extracellular matrix remodeling or fluid/solute secretion. Ptx2, Alox15b, OSP, and PCNA were all found in common and upregulated compared with age-matched ϩ/ϩ kidneys at both 3 and 7 days [Ptx2: 3.26-fold change (FC) at 3 days and 3.09 FC at 7 days; Alox15b: 2.70 FC at 3 days and 2.53 FC at 7 days; OSP: 1.82 FC at 3 days and 2.98 FC at 7 days; and PCNA: 1.70 FC at 3 days and 2.23 FC at 7 days].
Real-time RT-PCR validation of microarray results. To confirm that the mRNAs detected by DNA microarray screening in early-stage PKD were upregulated, we performed realtime RT-PCR analysis for Ptx2, Alox15b, OSP, and PCNA. As shown in Fig. 1 , the relative expression levels of Ptx2, Alox15b, OSP, and PCNA were significantly increased in Cy/Cy kidneys at 3 and 7 days compared with 3-day ϩ/ϩ kidneys.
RXR protein level and cellular distribution in rodent polycystic kidneys. To detect RXR protein levels, we performed Western blot analysis. At 3 days of age, RXR expression levels in Cy/Cy kidneys were significantly higher compared with ϩ/ϩ kidneys (Fig. 2) . At 7 days of age, no significant difference was seen between Cy/Cy and ϩ/ϩ kidneys, although there was a trend upward and the levels were already high. To examine the cellular distribution of RXR in the kidney, we performed immunohistochemistry. In ϩ/ϩ kidneys at 3 and 7 days, RXR immunoreactivity was only weakly observed in most nuclei of renal tubular epithelia (Fig. 3, B, H, and I) . In Cy/Cy kidneys at 3 and 7 days, RXR immunoreactivity was at higher levels not only in cystforming cells but also apparently in normal renal tubular epithelia, and sometimes apically (Fig. 3, D, K, and L) . In some cysts, RXR was observed in both the nucleus and cytoplasm (Fig. 3, D , K, and L, asterisk). Interestingly, in cells that were positive for RXR staining, strong PCNA staining was also observed (Fig. 3, C and J, asterisk) . These findings suggest that RXR may relate to early-stage cystogenesis via cellular proliferation mechanisms.
DISCUSSION
In the current study, global gene expression profiling was performed in the Pkdr1 rat to elucidate novel cell signaling pathways related to cystogenesis in early-stage PKD. Genes related to RXR-associated pathways were among the most frequently represented. By GO analysis, the functions of these RXR-related genes were found to be involved in regulating cell proliferation and organ morphogenesis. Included among these differentially expressed genes were Ptx2, Alox15b, and OSP.
The Ptx2 (Pitx2) gene encodes a member of the RIEG/PITX homeobox family. The Ptx2 protein colocalizes in the S3 segment of proximal tubules with GCMa (glial cells missing). It is a transcription factor that plays a critical role as a master regulator during development (40) . RXR binds ␤-catenin, and together they may increase expression of Ptx2 mRNA (38, 51) . The increased expression of the Ptx2 gene and its association with RXR/(NR/TR)-mediated pathways ( Fig. 1) suggest that the Ptx2 protein may be involved in early-stage development of PKD. The Alox15b (15-LOX-2) protein, which localizes to the distal nephron, is one of the isoforms of anticarcinogenic lipoxygenase (37) . Alox15b is preferentially expressed in normal tissue and benign lesions but not in carcinomas (10, 42, 45) . The elevated expression of Alox15b in early-stage PKD (Fig. 1) is consistent with the type of cell proliferation that is seen in benign tissues rather than malignant carcinoma. It is also possible that this gene is upregulated as a feedback mechanism to slow or prevent cell proliferation, dedifferentiation, apoptosis, and/or angiogenesis in early-stage PKD. The Alox15b enzyme produces 15-S-hydroxyeicosatetraenoic acid, an endogenous ligand for PPAR-␥, which in turn heterodimerizes with RXR (44) . Thus increased Alox15b expression may have an important role in cytogenesis through a PPAR-␥ nuclear receptor signaling cascade that includes RXR.
OSP, a secreted glycoprotein, is mainly present in the loop of Henle and distal nephrons in normal kidneys (52) . In a previous report, we found that OSP was markedly upregulated in the kidneys of 2-and 3-wk-old Cy/Cy rats (6). In the current study, the expression of OSP is shown to be involved in cell proliferation and morphogenesis in 3-and 7-day Cy/Cy kidneys. These results suggest that OSP may be one of the key proteins for progression of early-stage PKD. OSP expression is known to be suppressed by retinoids, activators of both retinoic acid receptors (RARs) and RXRs in the kidney (19, 20) . Therefore, retinoids may be involved in controlling PKD progression via RXR-mediated signaling pathways through downregulation of the OSP gene in Cy rats.
Since the Ptx2, Alox15b, and OSP genes are all related to cell proliferation and organ morphogenesis associated with RXR/(NR/TR)-mediated pathways, cellular RXR signaling may have a critical role in the onset and/or progression of early-stage PKD. RXR-mediated pathways have been reported to be associated with some types of cancers, including renal cell carcinoma (2, 8, 16, 18 ). In the current study, we found increased expression of RXR and the cell proliferation marker PCNA, and their colocalization in cystic epithelia, confirming a possible involvement of RXR signaling in the cell proliferation mechanisms of cyst-lining cells. Interestingly, recent global gene expression profiling for human ADPKD has shown upregulation of the RAR/ RXR pathway in accordance with renal cystic growth (43) . In addition to our current results, those findings in human disease also suggest the potential role of RXR-associated signaling in cystogenesis.
Heterodimers of RXR and other nuclear receptors are known to be activated by a number of agonists. For example, agonist-activated RXR/LXR inhibits cell proliferation and inflammatory responses (50, 58), and agonist-activated Fig. 2 . Retinoid X receptor (RXR) protein levels in 3-and 7-day-old Han:SPRD kidneys. RXR and GAPDH protein levels were determined by Western blot analysis for kidneys at 3 and 7 days of age. RXR expression levels were normalized to GAPDH. The RXR/GAPDH ratio was compared with 3-day ϩ/ϩ kidneys (set to 1.0). *P Ͻ 0.05, **P Ͻ 0.01. Fig. 1 . Relative gene expression levels for paired-like homeodomain transcription factor 2 (Ptx2), arachidonate 15-lipoxygenase, second type (Alox15b), secreted phosphoprotein 1 (OSP), and proliferating cell nuclear antigen (PCNA). mRNA expression levels are shown for ϩ/ϩ and Cy/Cy kidneys at 3 and 7 days, compared with 3-day ϩ/ϩ kidneys (set to 1.0). Expression levels were normalized to GAPDH. *P Ͻ 0.05, ** P Ͻ 0.01.
RXR/PPAR inhibits cell proliferation, fibrosis, and matrix metalloproteinase gene expression (3, 29, 55) . Therefore, it is possible that treatment with RXR/NR agonists may ameliorate PKD by inhibiting some of the pathways associated with this disease. Recently, Islam et al. (15) reported that activation of the human PKD1 promoter is controlled by vitamin A metabolites, 9-cis-retinoic acid (9c-RA), and all-trans retinoic acid (AT-RA) (15) . 9c-RA is known to be a ligand of RXR and RAR, and AT-RA is a ligand of RAR. These findings suggest that RXR/(NR/TR) agonists may ameliorate PKD in human patients as in rodent PKD. Because further studies would be required to establish this treatment for human patients, a determination of the effects of RXR/NR agonists in rodent models of PKD should be performed as the next step.
In conclusion, current results from pathway, GO, and realtime PCR analyses suggest that abnormal cellular proliferation and organ morphogenesis controlled by RXR-mediated pathways may have important roles in cystogenesis in early stages of PKD in Pkdr1-mutated Cy/Cy rats. As such, the current study provides a potential therapeutic strategy via a novel signaling pathway for ADPKD patients.
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